These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 758212)

  • 21. Purification of a heparin-neutralizing protein from rabbit platelets and its homology with human platelet Factor 4.
    Ginsberg MH; Hoskins R; Sigrist P; Painter RG
    J Biol Chem; 1979 Dec; 254(24):12365-71. PubMed ID: 115886
    [No Abstract]   [Full Text] [Related]  

  • 22. Improved method for purification of human platelet factor 4 by affinity and ion-exchange chromatography.
    Medici I; Di Martino A; Cella G; Callegaro L; Prosdocimi M
    Thromb Res; 1989 May; 54(4):277-87. PubMed ID: 2763268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo release and turnover of secreted platelet antiheparin proteins in rhesus monkey (Macaca mulatta).
    Musial J; Niewiarowski S; Edmunds LH; Addonizio VP; Nicolaou KC; Colman RW
    Blood; 1980 Oct; 56(4):596-607. PubMed ID: 6158350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a chondroitin 4 -sulfate proteoglycan carrier for heparin neutralizing activity (platelet factor 4 ) released from human blood platelets.
    Barber AJ; Käser-Glanzmann R; Jakábová M; Lüscher EF
    Biochim Biophys Acta; 1972 Dec; 286(2):312-29. PubMed ID: 4267228
    [No Abstract]   [Full Text] [Related]  

  • 25. Human platelet factor 4: preparation from outdated platelet concentrates and application in cerebral vascular disease.
    Levine PH; Fisher M; Fullerton AL; Duffy CP; Hoogasian JJ
    Am J Hematol; 1981 Jun; 10(4):375-85. PubMed ID: 7246539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antiheparin effect of alpha1-acid glycoprotein and platelet material, evaluated by the heparin thrombin clotting time.
    Andersen P; Godal HC
    Haemostasis; 1977; 6(6):339-46. PubMed ID: 611047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification of two heparin-binding proteins from porcine platelets and their homology with human secreted platelet proteins.
    Rucinski B; Poggi A; James P; Holt JC; Niewiarowski S
    Blood; 1983 Jun; 61(6):1072-80. PubMed ID: 6839017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of a monoclonal IgA with antiheparin activity.
    Szondy E; Beaumont JL
    Immunobiology; 1980 Dec; 157(4-5):407-13. PubMed ID: 6778818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antiheparin effect of alpha1-acid glycoprotein probably due to steric hindrance of the heparin-thrombin interaction.
    Andersen P; Godal HC
    Thromb Res; 1979; 15(5-6):857-68. PubMed ID: 494182
    [No Abstract]   [Full Text] [Related]  

  • 30. Platelet factor 4 antigen in megakaryocytes.
    Ryo R; Proffitt RT; Poger ME; O'Bear R; Deuel TF
    Thromb Res; 1980 Mar; 17(5):645-52. PubMed ID: 6992332
    [No Abstract]   [Full Text] [Related]  

  • 31. A study of antiheparin activity of serum and platelet factor 4.
    Sear CH; Poller L
    J Clin Pathol; 1972 Nov; 25(11):1007. PubMed ID: 4648526
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiheparin activity of human serum and platelet factor 4.
    Sear CH; Poller L
    Thromb Diath Haemorrh; 1973 Sep; 30(1):93-105. PubMed ID: 4806356
    [No Abstract]   [Full Text] [Related]  

  • 33. Identity between human and monkey platelet factor 4 antigen(s) in a RIA system.
    Fabrizi P; Barbarulli G; Castellani M; Tarli P
    Thromb Res; 1981 Jan 1-15; 21(1-2):165-8. PubMed ID: 7233398
    [No Abstract]   [Full Text] [Related]  

  • 34. Neutralization of the antiheparin activity of platelet factor 4 by a monoclonal antibody.
    Saggin L; Cazzola F; Corona G; Salvatico E; Cella G; Prosdocimi M
    Thromb Haemost; 1992 Jan; 67(1):137-43. PubMed ID: 1377413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assay of platelet factor 4 in plasma.
    Fuster V; Kazmier FJ; Cash JD; Bowie EJ; Owen CA
    Mayo Clin Proc; 1973 Feb; 48(2):103-6. PubMed ID: 4689655
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of heparin on the in vivo release and clearance of human platelet factor 4.
    Rao AK; Niewiarowski S; James P; Holt JC; Harris M; Elfenbein B; Bastl C
    Blood; 1983 Jun; 61(6):1208-14. PubMed ID: 6839021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet antiheparin activity. The isolation and characterisation of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity.
    Moore S; Pepper DS; Cash JD
    Biochim Biophys Acta; 1975 Feb; 379(2):370-84. PubMed ID: 1122293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and molecular characterization of human fibroblast interferon.
    Friesen HJ; Stein S; Evinger M; Familletti PC; Moschera J; Meienhofer J; Shively J; Pestka S
    Arch Biochem Biophys; 1981 Feb; 206(2):432-50. PubMed ID: 6164342
    [No Abstract]   [Full Text] [Related]  

  • 39. Rat platelets contain glycosylated and non-glycosylated forms of platelet factor 4. Identification and characterization by mass spectrometry.
    Ravanat C; Gachet C; Herbert JM; Schuhler S; Guillemot JC; Uzabiaga F; Picard C; Ferrara P; Freund M; Cazenave JP
    Eur J Biochem; 1994 Jul; 223(1):203-10. PubMed ID: 8033893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin-Sepharose affinity chromatography.
    Farooqui AA; Horrocks LA
    Adv Chromatogr; 1984; 23():127-48. PubMed ID: 6322544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.